AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
AAPL   318.43 (+0.06%)
MSFT   181.85 (+0.25%)
FB   224.67 (-0.35%)
AMZN   2,412.23 (+0.46%)
NVDA   344.04 (+1.34%)
CGC   17.80 (-18.05%)
BABA   197.81 (-0.84%)
MU   46.72 (+0.54%)
GE   6.55 (-3.39%)
AMD   52.52 (+1.51%)
T   30.65 (-1.32%)
ACB   13.90 (-9.39%)
F   5.71 (-2.40%)
DIS   115.95 (-0.69%)
NFLX   416.01 (+0.62%)
BA   145.78 (-2.70%)
Log in

OTCMKTS:CSLLYCommonwealth Bank of Australia Stock Price, Forecast & News

$95.66
-0.44 (-0.46 %)
(As of 05/29/2020 08:57 AM ET)
Add
Compare
Today's Range
$95.00
Now: $95.66
$96.20
50-Day Range
$95.86
MA: $99.78
$104.91
52-Week Range
$69.98
Now: $95.66
$114.40
Volume34,027 shs
Average Volume42,310 shs
Market Capitalization$86.86 billion
P/E Ratio45.12
Dividend Yield0.86%
Beta0.67
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. It also operates approximately 140 plasma collection centers. In addition, this segment conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and developsinfluenza vaccines. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.19 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CSLLY
CUSIPN/A
CIKN/A
Phone61-3-9389-1911

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.54 billion
Cash Flow$2.52 per share
Book Value$5.80 per share

Profitability

Miscellaneous

Employees25,000
Market Cap$86.86 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive CSLLY News and Ratings via Email

Sign-up to receive the latest news and ratings for CSLLY and its competitors with MarketBeat's FREE daily newsletter.

Commonwealth Bank of Australia (OTCMKTS:CSLLY) Frequently Asked Questions

How has Commonwealth Bank of Australia's stock been impacted by COVID-19 (Coronavirus)?

Commonwealth Bank of Australia's stock was trading at $101.09 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CSLLY stock has decreased by 5.4% and is now trading at $95.6550. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Commonwealth Bank of Australia?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Commonwealth Bank of Australia in the last year. There are currently 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Commonwealth Bank of Australia.

How often does Commonwealth Bank of Australia pay dividends? What is the dividend yield for Commonwealth Bank of Australia?

Commonwealth Bank of Australia declared a Semi-Annual dividend on Thursday, August 15th. Stockholders of record on Tuesday, September 10th will be paid a dividend of $0.45 per share on Monday, October 21st. The ex-dividend date of this dividend is Monday, September 9th. View Commonwealth Bank of Australia's dividend history.

Has Commonwealth Bank of Australia been receiving favorable news coverage?

Press coverage about CSLLY stock has been trending extremely negative on Friday, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Commonwealth Bank of Australia earned a daily sentiment score of -4.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutCommonwealth Bank of Australia.

Who are some of Commonwealth Bank of Australia's key competitors?

Who are Commonwealth Bank of Australia's key executives?

Commonwealth Bank of Australia's management team includes the following people:
  • Mr. Paul R. Perreault, MD, CEO & Exec. Director (Age 62)
  • Mr. David Mark Lamont ACA, BCom, Chief Financial Officer (Age 53)
  • Dr. Robert Andrew Cuthbertson, Chief Scientific Officer & Director of R&D and Director (Age 64)
  • Mr. Gregory Boss BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel (Age 58)
  • Ms. Elizabeth Walker, Exec. VP & Chief HR Officer (Age 49)

What is Commonwealth Bank of Australia's stock symbol?

Commonwealth Bank of Australia trades on the OTCMKTS under the ticker symbol "CSLLY."

How do I buy shares of Commonwealth Bank of Australia?

Shares of CSLLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Commonwealth Bank of Australia's stock price today?

One share of CSLLY stock can currently be purchased for approximately $95.66.

How big of a company is Commonwealth Bank of Australia?

Commonwealth Bank of Australia has a market capitalization of $86.86 billion and generates $8.54 billion in revenue each year. The company earns $1.92 billion in net income (profit) each year or $2.12 on an earnings per share basis. Commonwealth Bank of Australia employs 25,000 workers across the globe.

What is Commonwealth Bank of Australia's official website?

The official website for Commonwealth Bank of Australia is www.csl.com.au.

How can I contact Commonwealth Bank of Australia?

Commonwealth Bank of Australia's mailing address is 45 Poplar Road, Parkville C3, 3052. The company can be reached via phone at 61-3-9389-1911 or via email at [email protected]

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.